Unquote Private Equity Podcast: Venture's immunity
The Unquote podcast turns its attention to venture, which has showcased its resilience in recent months and could see its attractiveness boosted further in a post-pandemic world
While much of Unquote's editorial output in recent months has been focused on the impact of the Covid-19 crisis on the European buyout market, tallying up the numbers for 2020 highlights that venture capital activity weathered the storm impressively.
Looking at the entire segment, dealflow was up 10% year-on-year compared with 2019 numbers, with aggregate value ever so slightly down (but, at €37.5bn overall, still way ahead of the historical average over the previous decade). Early-stage VC was even more resilient, and, across the board, the sudden impact of the outbreak early in the year did not impact momentum in Q2.
For this venture special, Katharine Hidalgo hosts Unquote editor Greg Gille and Simon Philips, CEO of ScaleUp Capital, to discuss key takeaways and the outlook for the European venture space. She then welcomes Alessia Argentieri, Unquote's southern Europe specialist, for a deep dive into the trends at play in that market.
0:00 – Intro
1:54 – Market overview
7:42 – Venture's strengths
11:51 – Fundraising outlook
14:34 – Talking valuations
16:40 – Southern Europe deep dive
You can listen to the podcast in the audio player above, as well as your favourite podcasting platforms, including Spotify and Apple Podcasts.
Theme music: ©2012 Kick Up The Fire
Alantra reshuffles investment banking division headed by new CEO
Miguel Hernández takes on CEO role after more than 20 years with the financial advisory firm
Sofinnova launches digital medicine strategy
Life sciences sponsor’s sixth strategy will deploy EUR 2m-EUR 8m tickets in seed and Series A
Quadrivio plans first close for EUR 500m Lifestyle Fund II by mid-2023
Italy-based GP will expand predecessor Made in Italy vehicle’s focus beyond Italy to target European SMEs
AnaCap reaps 4.3x on MRH Trowe minority stake sale to TA Associates
German insurance broker will now be backed by both GPs; deal comes 2.5 years into AnaCap's investment period